Ann Childress, MD

  • 2Articles
  • 26.6KReads
  • 2021–2024Active
  • 8Collaborators
  • 6Citations

About

Ann Childress, MD, is affiliated with the Department of Family Medicine at the Kirk Kerkorian School of Medicine at UNLV and Touro University Nevada College of Osteopathic Medicine. Her publications focus on Attention-Deficit/Hyperactivity Disorder (ADHD) in adults, including diagnostic trends, treatment barriers, telehealth utilization, and clinical trials evaluating new formulations of amphetamine sulfate. She has contributed to research on neurodevelopmental disorders and has served as the immediate past-president of the American Professional Society of ADHD and Related Disorders (APSARD).

Publications

JCP
Clinical Implications of Adult ADHD: What New Data Tell Us
Commentary

Clinical Implications of Adult ADHD: What New Data Tell Us

October 10, 2024

The authors discuss striking new findings from the Morbidity and Mortality Weekly Report on the burden of adult ADHD, demonstrating the need for the upcoming APSARD Adult ADHD Guidelines.
,
JCP
Original Research

Efficacy and Safety of AR19 in Adults With ADHD

August 24, 2021

Misuse of stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) can have adverse medical outcomes. This study tested the safety and efficacy of AR19, a manipulation-resistant formulation of amphetamine, in...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe